Report of Massachusetts specific Open Payments Program data

See the data reports required under the Physician Payments Sunshine Act.

The Physician Payments Sunshine Act requires manufacturers of drugs, medical devices, and biologics that participate in U.S. federal health care programs to report certain payments and items of value given to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services (CMS) has been charged with implementing the Sunshine Act and has called it the Open Payments Program.

Section 8 of the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct, chapter 111N of the General Laws, requires the department of public health to make all disclosed data in annual reports publicly available and easily searchable on its website not later than 90 days following the receipt thereof.

In compliance with this mandate, this report shows the state-specific data received on September 30, 2014 from the Open Payments Program. In addition to this federal data, the state also collects data for payments made to non-teaching hospitals and non-physician practitioners by pharmaceutical and medical device manufacturers with marketing activity in the commonwealth. This annual data is reported separately and is not included in this report. The Open Payments Program report is divided into three sections, as follows:

All Open Payments Data

General Payments Data

Payments or other transfers of value not made in connection with a research agreement or research protocol.

Research Payments

Payments or other transfers of value made in connection with a research agreement or research protocol.

Physician Ownership Information

Information about physicians who have an ownership or investment interest in an applicable manufacturer or applicable GPO.